Short and Mid-term Repeatability of Active Anterior Rhinomanometry (AAR) Measurements in Paediatric Age
Rhino-Rep
1 other identifier
observational
50
1 country
1
Brief Summary
Longitudinal, observational study to assess the short-term (test re-test) and mid-term (within the span of 28 days) repeatability of active anterior rhinomanometry (AAR) measures on 4 parallel groups of children with different rhinitis phenotypes, and 1 group of control (healthy) children. Secondary objectives are: i) assessing of association between AAR, exhaled FeNO (eFeNO) and nasal FeNO (nFeNO); ii) assessing association between objective measurements (AAR, eFeNO and nFeNO) and subjective measurements (Total 5 Symptom score, T5SS). The study is intended to obtain useful information for improving rhinitis management.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2018
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 5, 2017
CompletedFirst Posted
Study publicly available on registry
September 18, 2017
CompletedStudy Start
First participant enrolled
January 10, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2018
CompletedNovember 16, 2018
November 1, 2018
7 months
September 5, 2017
November 15, 2018
Conditions
Outcome Measures
Primary Outcomes (2)
Short term repeatability of active anterior rhinomanometry (AAR)
For each individual, it will be calculated the coefficient of variation of 5 measurements of AAR taken within 30 minutes, at baseline.
1 day
Mid term repeatability of active anterior rhinomanometry (AAR)
For each individual, it will be calculated the coefficient of variation of 3 measurements of AAR taken at baseline and then twice more within the span of 28 days (after one week and after two weeks).
28 days
Secondary Outcomes (4)
Correlation between AAR and oral FeNO
28 days
Correlation between AAR and nasal FeNO
28 days
Correlation between AAR (objective perspective) and T5SS (subjective perspective)
28 days
Correlation between FeNO (objective perspective) and T5SS (subjective perspective)
28 days
Study Arms (5)
Healthy children (HC)
10 healthy children
Children with non allergic rhinitis (NAR)
10 children with non allergic rhinitis
Rhinitis children, perennial allergy (PAR)
10 rhinitis children, sensitized to perennial allergens
Rhinitis children, seasonal allergy, outside season (OSR)
10 rhinitis children sensitized to seasonal allergens, observed outside the allergen season
Rhinitis children, seasonal allergy, within season (WSR)
10 rhinitis children sensitized to seasonal allergens, observed during the allergen season
Eligibility Criteria
A study population of 40 rhinitis children (10 for each of 4 different rhinitis phenotypes) attending the outpatient clinic of Pediatric Allergology \& Pulmonology (PAP) within the Institute of Biomedicine and Molecular Immunology (IBIM) of the National Research Council (CNR) of Palermo (IBIM CNR), and a control group of 10 healthy volunteers.
You may qualify if:
- Negative bronchodilator response;
- No major nasal septum malformations.
You may not qualify if:
- Upper airway infections in the previous 4 weeks;
- Active smoker;
- Lifetime history of asthma, rhinitis, or respiratory disease symptoms.
- Children with non allergic rhinitis (NAR)
- T5SS\>5 in the last 4 weeks.
- At least one positive skin prick test for aeroallergens;
- Upper airway infections in the previous 4 weeks;
- Active smoker;
- Major nasal septum malformations.
- Rhinitis children, perennial allergy (PAR)
- T5SS\>5 in the last 4 weeks.
- At least one positive skin prick test for perennial aeroallergens;
- At least one positive skin prick test for seasonal aeroallergens;
- Upper airway infections in the previous 4 weeks;
- Active smoker;
- +15 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council
Palermo, Sicily, 90146, Italy
Related Publications (1)
Cilluffo G, Zicari AM, Ferrante G, Malizia V, Fasola S, Duse M, De Castro G, De Vittori V, Schiavi L, Brindisi G, Petrelli P, La Grutta S. Assessing repeatability and reproducibility of Anterior Active Rhinomanometry (AAR) in children. BMC Med Res Methodol. 2020 Apr 17;20(1):86. doi: 10.1186/s12874-020-00969-1.
PMID: 32303189DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Ph.D. Senior Researcher. Coordinator of Pediatric Allergy and Asthma Research Group. Institute of Biomedicine and Molecular Immunology, IBIM, National Research Council of Palermo, Italy.
Study Record Dates
First Submitted
September 5, 2017
First Posted
September 18, 2017
Study Start
January 10, 2018
Primary Completion
July 31, 2018
Study Completion
July 31, 2018
Last Updated
November 16, 2018
Record last verified: 2018-11